| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | NEUTRAL | NEUTRAL | NEUTRAL | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | N/A | N/A | N/A | N/A | N/A |
| MA10 | N/A | N/A | N/A | N/A | N/A |
| MA20 | N/A | N/A | N/A | N/A | N/A |
| MA50 | N/A | N/A | N/A | N/A | N/A |
| MA100 | N/A | N/A | N/A | N/A | N/A |
| MA200 | N/A | N/A | N/A | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | N/A | N/A | N/A | N/A | N/A |
| RSI | N/A | N/A | N/A | N/A | N/A |
| STOCH | N/A | N/A | N/A | N/A | N/A |
| WILL %R | N/A | N/A | N/A | N/A | N/A |
| CCI | N/A | N/A | N/A | N/A | N/A |
|
Friday, August 07, 2026 02:02 PM
BlossomHill Therapeutics priced its IPO at $16 a share, raising $150 million with J.P. Morgan and Leerink leading the book. A deal that size for a precision oncology developer is a real test of how ...
|
|
Tuesday, August 04, 2026 11:37 AM
Mineral rights owner Black Stone Minerals (NYSE:BSM) reported Q2 CY2026 results , but sales fell by 6.6% year on year to $149 million. Its non-GAAP profit of $0.30 per share was 20% above analysts’ ...
|
|
Monday, August 03, 2026 03:15 PM
Mineral rights owner Black Stone Minerals (NYSE:BSM) reported Q2 CY2026 results , but sales fell by 6.6% year on year to $149 million. Its GAAP profit of $0.47 per share was significantly above ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 10/08/26 | 16.50 | 17.2488 | 15.97 | 15.99 | 417,900 |
|
|
||||
|
|
||||
|
|